John Bryan Clifton,J Cannon Clifton,Mark Alan Moran,Scott Patrick Worrich
申请号：
US16101217
公开号：
US20200046683A1
申请日:
2018.08.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Methods for treatment for patients having depression and/or pain are contemplated as including an administration of first preparation comprising an antiemetic agent, preferably ondansetron, followed by a second preparation of a synergistic combination of ketamine and a benzodiazepine, preferably lorazepam, administered via a continuous intravenous infusion. Such methods may be seen to better alleviate depression and pain symptoms, and may result in reduced need for other medications.
